510(k) Report

510(k) · Cleared

Cleared

MAMMOVISTA B.smart (VB70)

K223363510(k) SpecialCleared Jan 12, 202370-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Medical Solutions USA, Inc. · LLZ System, Image Processing, Radiological

Cleared on Jan 12, 2023 as substantially equivalent to K212621 (Siemens Medical Solutions USA, Inc., 2021) after a 70-day review. Its family tree reaches back 5 generations to 2003.

Decided
Jan 12, 2023
Review
70 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K033712 (2003). 8 ancestors in all, the oldest K010938 (2001). No later device cites it as a predicate yet.

  1. Root · 5 generations backK033712 Modification to Sectra IDS5 Radiology Workstation - Version 10.1Sectra-Imtec AB · 2003
  2. 4 generations backK040376 Sectra IDS5 Radiology Workstation; Sectra MPR Package; Sectra 3D…Sectra-Imtec AB · 2004
  3. 3 generations backK042868 Mammoreport Softcopy WorkstationSiemens Medical Solutions USA, Inc. · 2005
  4. 2 generations backK123420 Syngo, Breast CareSiemens Medical Solutions USA, Inc. · 2013 · Recalled
  5. 1 generation backK212621 MAMMOVISTA B.smartSiemens Medical Solutions USA, Inc. · 2021
  6. This deviceK223363 MAMMOVISTA B.smart (VB70)Siemens Medical Solutions USA, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K033712Modification to Sectra IDS5 Radiology Workstation - Version 10.1Sectra-Imtec AB2003—
−4K040376Sectra IDS5 Radiology Workstation; Sectra MPR Package; Sectra 3D PackageSectra-Imtec AB2004—
−3K042868Mammoreport Softcopy WorkstationSiemens Medical Solutions USA, Inc.2005—
−2K123420Syngo, Breast CareSiemens Medical Solutions USA, Inc.20131
−1K212621MAMMOVISTA B.smartSiemens Medical Solutions USA, Inc.2021—
0 (this device)K223363MAMMOVISTA B.smart (VB70)Siemens Medical Solutions USA, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200420
FIG. 1 — Lineage of K223363, 2003–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K212621MAMMOVISTA B.smart
Summary page 5
…4. Legally Marketed Predicate Device: Trade Name: MAMMOVISTA B.smart 510(k) Number: K212621 (Cleared 11/12/2021) Classification Name: Medical Image Management and…
Siemens Medical Solutions USA, Inc.2021—

Also cleared against K212621: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 1.2 years on median.
  • 4 of the 8 ancestors have a recall of any class.
  • 1 other device also cites its predicate K212621.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

MAMMOVISTA B.smart is a dedicated softcopy review environment for both screening and diagnostic mammography as well as digital breast tomosynthesis. Its user interface and workflow have been optimized to support experienced mammography and tomosynthesis reviewers in both screening and diagnostic reading. Efficiency and reading quality are supported by various specialized features. MAMMOVISTA B.smart provides visualization and image enhancement tools to aid a qualified radiologist in the review of digital mammography and digital breast tomosynthesis datasets, as well as other modalities of breast images.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223363: MAMMOVISTA B.smart (VB70).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K223363

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026